Tech Company Financing Transactions
CVRx Funding Round
CVRx, based in Minneapolis, scored $12 million in funding from DaVita HealthCare Partners and Ysios Capital.
Transaction Overview
Company Name
Announced On
10/31/2013
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series F
Investors
Ysios Capital (Josep Sanfeliu)
Proceeds Purpose
CVRx plans to use the funding for the primary purposes of advancing its clinical trials and expanding its international commercial activities.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
9201 West Broadway Ave. 650
Minneapolis, MN 55445
USA
Minneapolis, MN 55445
USA
Phone
Website
Email Address
Overview
CVRx developed an implantable technology, called Barostim neo, for the treatment of high blood pressure and heart failure.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nadim Yared
Chief Financial Officer
John Brintnall
VP - R & D
Liz Galle
VP - Regulatory Affairs
Dean Bruhn-Ding
Browse more venture capital transactions:
Prev: 10/31/2013: Rethink Robotics venture capital transaction
Next: 10/31/2013: LOYAL3 venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs